Admin, Author at Immetas

Immetas Therapeutics and GC Biopharma Announce Research Collaboration to Discover and Develop mRNA Therapeutics to Treat Autoimmune Diseases

East Hanover, NJ and Yongin, South Korea -October 12, 2023 – Immetas Therapeutics and GC Biopharma today announced that they have entered into a research collaboration

Admin May 1, 2024

Immetas Therapeutics Announces Series A Financing to Advance Research on Inflammation Pathways in Aging and Develop Therapeutics for Cancer and Inflammatory Disease

East Hanover, NJ – September 23, 2020 – Immetas Therapeutics today announced it has raised a Series A financing of $11 million to advance research on inflammation pathways in

Admin September 22, 2020

Immetas Therapeutics and GC Biopharma Announce Research Collaboration to Discover and Develop mRNA Therapeutics to Treat Autoimmune Diseases

Immetas Therapeutics Announces Series A Financing to Advance Research on Inflammation Pathways in Aging and Develop Therapeutics for Cancer and Inflammatory Disease

This website uses cookies to ensure you get the best experience on our website.